论文部分内容阅读
多发性硬化(MS)的诊断核心始终围绕着疾病的时间多发与空间多发性。虽然当前确定的一些MS诊断标准已被广泛接受,但是没有一种疾病的出现与发展会按诊断标准的内容要求而罗列在临床医生案前。MS的诊断仍然是基于临床的一个综合性判断与排它性诊断。循证医学证据表明几种修饰药物治疗MS具有一定效果。MS完整的治疗方案仍应结合临床分型、活动度、分期等制定,治疗的范围包括控制急性发作、预防复发与进展、处理症状及康复神经功能四方面,而且考虑到医疗制度、经济水平和外界因素的影响,治疗需个体化。
Multiple sclerosis (MS) diagnostic center has always been around the disease with multiple and spatial multiple. Although some of the currently established diagnostic criteria for MS have become widely accepted, no single disease has been identified and presented by clinicians in accordance with the diagnostic criteria. The diagnosis of MS is still based on a comprehensive clinical diagnosis and exclusive diagnosis. Evidence-based medical evidence suggests that several modified medications have some effect on MS. MS complete treatment plan should still be combined with clinical classification, activity, staging, etc., the scope of treatment includes the control of acute attacks, prevention of recurrence and progression, treatment of symptoms and rehabilitation of nerve function in four areas, and taking into account the medical system, economic and External factors, the treatment needs to be individualized.